197 related articles for article (PubMed ID: 26475125)
1. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
4. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
Reichert JA; Hlavinka PF; Stolzfus JC
Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
Yang LS; Alukaidey S; Croucher K; Dowling D
Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
[TBL] [Abstract][Full Text] [Related]
10. Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.
Davis JPE; O'Leary KE; Intagliata NM
Eur J Haematol; 2020 Mar; 104(3):223-229. PubMed ID: 31797441
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
12. Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Dang JD; Davis LE
JAAPA; 2015 Jun; 28(6):27-8, 30. PubMed ID: 25989432
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Use of Pharmacologic Venous Thromboembolism Prophylaxis in Post-Traumatic Brain Injury Patients.
Saadi R; Brandt K; Madlinger R; Nerenberg SF
J Pharm Pract; 2021 Dec; 34(6):864-869. PubMed ID: 32508232
[TBL] [Abstract][Full Text] [Related]
14. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease.
Bogari H; Patanwala AE; Cosgrove R; Katz M
Thromb Res; 2014 Dec; 134(6):1220-3. PubMed ID: 25294587
[TBL] [Abstract][Full Text] [Related]
15. Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury.
Chang R; Scerbo MH; Schmitt KM; Adams SD; Choi TJ; Wade CE; Holcomb JB
J Trauma Acute Care Surg; 2017 Dec; 83(6):1088-1094. PubMed ID: 28863085
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
17. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
19. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
[TBL] [Abstract][Full Text] [Related]
20. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
